ASPG and hyperlipidemia: However, asparaginase is associated with various toxicities, including hypersensitivity, pancreatitis, hyperlipidaemia, hepatotoxicity, thrombosis, and osteonecrosis, which may lead to the discontinuation of asparaginase therapy (2).